Tests and expenditures in the initial evaluation of peripheral neuropathy

Archives of Internal Medicine

Volumn 172, Issue 2, 2012, Pages 127-132

  Callaghan, Brian ^a   McCammon, Ryan ^a   Kerber, Kevin ^a   Xu, Xiao ^a   Langa, Kenneth M ^a,b   Feldman, Eva ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA CENTER FOR CLINICAL MANAGEMENT RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; PLASMA PROTEIN; THYROTROPIN;

ARTICLE; BLOOD CELL COUNT; DIABETES MELLITUS; DIAGNOSTIC TEST; ELECTRODIAGNOSIS; ELECTROPHORESIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HEALTH CARE COST; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICARE; METABOLIC PARAMETERS; NERVE CONDUCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

AGED; ANTIBODIES, ANTINUCLEAR; BLOOD CELL COUNT; BLOOD PROTEIN ELECTROPHORESIS; BLOOD SEDIMENTATION; BRAIN; DIAGNOSTIC TESTS, ROUTINE; ELECTROMYOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MEDICARE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY ASSURANCE, HEALTH CARE; SPINE; THYROTROPIN; UNITED STATES; VITAMIN B 12;

EID: 84862907551     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.1032     Document Type: Article

References (17)

1. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991;41(8):1315-1317.
2. Savettieri G, Rocca WA, Salemi G, et al Sicilian Neuro-Epidemiologic Study (SNES) Group. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Neurology. 1993;43(6):1115-1120. (Pubitemid 23177709)
3. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27(7):1591-1597. (Pubitemid 38857431)
4. England JD, Gronseth GS, Franklin G, et al American Academy of Neurology. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review): report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):185-192.
5. Smith AG, Singleton JR. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med. 2004;164(9):1021-1025. (Pubitemid 38581524)
6. Palumbo PJ, Elveback LR, Whisnant JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol. 1978;19:593-601.
7. Saperstein DS, Wolfe GI, Gronseth GS, et al. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol. 2003;60(9):1296-1301. (Pubitemid 37099639)
8. Kelly JJ Jr, Kyle RA, O'Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981;31(11):1480-1483. (Pubitemid 12228290)
9. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24(9):1229-1231. (Pubitemid 32762153)
10. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001; 24(8):1448-1453. (Pubitemid 33716436)
11. McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry. 1984;47(5):530-535. (Pubitemid 14145504)
12. Rector TS, Wickstrom SL, Shah M, et al. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res. 2004;39(6, pt 1):1839-1857. (Pubitemid 39601255)
13. Dyck PJ, Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? review of previous studies and design of a prospective controlled population-based study. Muscle Nerve. 2007;36(4):536-541. (Pubitemid 47512081)
14. Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain. 2004;127(pt 8):1723-1730. (Pubitemid 39061549)
15. Kissel JT. Peripheral neuropathy with impaired glucose tolerance: a sweet smell of success? Arch Neurol. 2006;63(8):1055-1056.
16. Knowler WC, Barrett-Connor E, Fowler SE, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. (Pubitemid 34437694)
17. Santos-Rey K, Fernández-Riejos P, Mateo J, Sánchez-Margalet V, Goberna R. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals. Clin Chem Lab Med. 2010;48(12):1719-1722.